目的 分析2015-2016年曲靖市第一人民医院注射用辅助用药的使用情况，为医院管理和临床规范使用提供参考。方法 2015-2016年曲靖市第一人民医院注射用辅助用药的使用数据，对使用金额、药占比、用药频度（DDDs）等进行统计分析。结果 2015-2016年辅助用药的使用金额和药占比具显著下降。进入全院药品金额排名前20位的辅助用药品种数也降低。注射用红花黄色素的使用金额从2015年的第1位降到2016年的第15位，注射用血栓通则从2015年的第2位降到2016年的15位之外。2015-2016年维生素B₆注射液的DDDs均排名第1位。2015、2016年，上报的药品不良反应分别为15、6例。2015-2016年主要不合理用药为无适应症用药和用法用量不合理，构成比分别为38.81%、30.00%，21.15%、20.50%，2016年较2015年不合理病例数明显降低。结论 加强辅助用药管理有效降低辅助用药费用和药占比，规范辅助用药使用，促进患者的用药安全。

Objective To investigate the utilization of adjuvant drugs for injection in Qujing First People's Hospital from 2015 to 2016, so as to provide reference for standard management and regular application in clinic. Methods Data of adjuvant drugs for injection in Qujing First People's Hospital from 2015 to 2016 were selected, and consumption sum, constituent ratio, and frequency of drug use (DDDs) were retrospectively analyzed. Results Consumption sum and constituent ratio of adjuvant drugs were significantly decreased from 2015 to 2016. The number of adjuvant drugs with top 20 consumption sum was dropped. Consumption sum of Safflower Yellow for injection ranked the first in 2015, and decreased to the fifth in 2016. Consumption sum of Xueshuantong for injection ranked the second in 2015, and decreased over the fifth in 2016. DDDs of Vitamin B₆ Injection ranked the first from 2015 to 2016. The cases of ADR were 15 and 6 in 2015 and 2016. The main irrational drug use was inappropriate indications and inappropriate usage and dosage, and the constituent ratio were 38.81% and 30.00%, 21.15% and 20.50%. Compared with those in 2015, the cases of irrational drug use were decreased in 2016. Conclusion The management of adjuvant drugs should be strengthened to effectively reduce the cost and proportion of adjuvant drugs, and standardized the application and promote the medication safety of patients.